INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Price, Forecast & Analysis
USA • New York Stock Exchange • NYSE:INSP • US4577301090
INSP Key Statistics, Chart & Performance
The current stock price of INSP is 71.95 USD. In the past month the price decreased by -20.4%. In the past year, price decreased by -59.68%.
INSP Technical Analysis
INSP Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to INSP. While INSP has a great health rating, its profitability is only average at the moment.
INSP Financial Highlights
Over the last trailing twelve months INSP reported a non-GAAP Earnings per Share(EPS) of 2.04. The EPS increased by 90.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.05% | ||
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| Debt/Equity | 0 |
INSP Forecast & Estimates
25 analysts have analysed INSP and the average price target is 142.79 USD. This implies a price increase of 98.46% is expected in the next year compared to the current price of 71.95.
For the next year, analysts expect an EPS growth of -17.67% and a revenue growth 13.49% for INSP
INSP Ownership
INSP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 21.08 | 188.81B | ||
| ISRG | INTUITIVE SURGICAL INC | 53.58 | 169.61B | ||
| SYK | STRYKER CORP | 26.39 | 137.53B | ||
| BSX | BOSTON SCIENTIFIC CORP | 30.97 | 135.43B | ||
| BDX | BECTON DICKINSON AND CO | 14.33 | 59.00B | ||
| IDXX | IDEXX LABORATORIES INC | 48.82 | 50.95B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.05 | 47.80B | ||
| RMD | RESMED INC | 24.54 | 36.83B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.13 | 35.81B | ||
| DXCM | DEXCOM INC | 38.49 | 27.93B | ||
| PODD | INSULET CORP | 54.81 | 17.62B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.67 | 17.11B |
Related stock screener links
About INSP
Company Profile
Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The company is headquartered in Golden Valley, Minnesota and currently employs 1,246 full-time employees. The company went IPO on 2018-05-03. The firm is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The firm sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Company Info
INSPIRE MEDICAL SYSTEMS INC
5500 Wayzata Blvd Ste 1600
Golden Valley MINNESOTA 55416 US
CEO: TimothyP. Herbert
Employees: 1246
Phone: 17639575037
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
What does INSPIRE MEDICAL SYSTEMS INC do?
Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The company is headquartered in Golden Valley, Minnesota and currently employs 1,246 full-time employees. The company went IPO on 2018-05-03. The firm is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The firm sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Can you provide the latest stock price for INSPIRE MEDICAL SYSTEMS INC?
The current stock price of INSP is 71.95 USD. The price decreased by -2.04% in the last trading session.
Does INSPIRE MEDICAL SYSTEMS INC pay dividends?
INSP does not pay a dividend.
What is the ChartMill technical and fundamental rating of INSP stock?
INSP has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
How is the market expecting INSP stock to perform?
25 analysts have analysed INSP and the average price target is 142.79 USD. This implies a price increase of 98.46% is expected in the next year compared to the current price of 71.95.
What is the GICS sector and industry of INSP stock?
INSPIRE MEDICAL SYSTEMS INC (INSP) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Can you provide the market cap for INSPIRE MEDICAL SYSTEMS INC?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a market capitalization of 2.09B USD. This makes INSP a Mid Cap stock.